Porton Advanced Solutions Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 66

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 14

Porton Advanced Solutions General Information

Description

Developer of gene and cell therapy development and production, intended to accelerate the commercialization of gene and cell therapies. The company operates an integrated platform featuring proprietary upstream and downstream process development, analytical method validation, current good manufacturing practice production, quality control, and quality assurance, enabling biotechnology and pharmaceutical companies to transition biological products from discovery to commercial production.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 3, Tengfei Innovation Park
  • Number 388 Xinping Street
  • Suzhou, Jiangsu 215121
  • China
+86 0512
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Building 3, Tengfei Innovation Park
  • Number 388 Xinping Street
  • Suzhou, Jiangsu 215121
  • China
+86 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Porton Advanced Solutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 31-Jul-2025 Completed Generating Revenue
2. Early Stage VC (Series B) 19-Aug-2022 Completed Generating Revenue
1. Early Stage VC (Series A) 16-Apr-2021 $61.1M $61.1M Completed Generating Revenue
To view Porton Advanced Solutions’s complete valuation and funding history, request access »

Porton Advanced Solutions Patents

Porton Advanced Solutions Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11879139-B1 Scalable methods for purification of recombinant viruses Active 20-Sep-2022
WO-2022207003-A1 Chimeric antigen receptors targeting albumin and their methods of uses Inactive 02-Apr-2021
WO-2022048621-A1 Compositions and methods to target anti-rh antibody Inactive 03-Sep-2020
US-20230287097-A1 Compositions and methods to target anti-tnf-alpha antibody Pending 16-Jul-2020
WO-2022012610-A1 Compositions and methods to target anti-tnf-alpha antibody Inactive 16-Jul-2020 C07K16/241
To view Porton Advanced Solutions’s complete patent history, request access »

Porton Advanced Solutions Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Porton Advanced Solutions Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
China Merchants Venture Capital Corporate Venture Capital Minority
Hainan Xinguoxing Private Equity Fund Management Growth/Expansion Minority
China Merchants Capital Asset Manager Minority
China Merchants Group Holding Company Minority
China Merchants Securities Asset Manager Minority
You’re viewing 5 of 14 investors. Get the full list »

Porton Advanced Solutions FAQs

  • When was Porton Advanced Solutions founded?

    Porton Advanced Solutions was founded in 2018.

  • Where is Porton Advanced Solutions headquartered?

    Porton Advanced Solutions is headquartered in Suzhou, China.

  • What is the size of Porton Advanced Solutions?

    Porton Advanced Solutions has 66 total employees.

  • What industry is Porton Advanced Solutions in?

    Porton Advanced Solutions’s primary industry is Drug Discovery.

  • Is Porton Advanced Solutions a private or public company?

    Porton Advanced Solutions is a Private company.

  • What is Porton Advanced Solutions’s current revenue?

    The current revenue for Porton Advanced Solutions is .

  • How much funding has Porton Advanced Solutions raised over time?

    Porton Advanced Solutions has raised $138M.

  • Who are Porton Advanced Solutions’s investors?

    China Merchants Venture Capital, Hainan Xinguoxing Private Equity Fund Management, China Merchants Capital, China Merchants Group, and China Merchants Securities are 5 of 14 investors who have invested in Porton Advanced Solutions.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process